Utility of the NeuroTrax Computerized Battery for Cognitive Screening in Parkinson's Disease: Comparison with the MMSE and the MoCA

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Neuroscience

• Publication date

  2010-07-01

• Fields of study

  Medicine, Computer Science, Psychology

• Identifiers
  DOI 10.3109/00207454.2010.496539PMID 20615057PMCID PMC4341831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VALIDITY OF THE MoCA AND MMSE IN THE DETECTION OF MCI AND DEMENTIA IN PARKINSON DISEASE

  2010influential reference
• Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US

  2009cited by this paper
• Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with “Normal” Global Cognition According to Mini‐Mental State Examination Score

  2009influential reference
• Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

  2009influential reference
• The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory.

  2008influential reference
• Status of computerized cognitive testing in aging: A systematic review

  2008cited by this paper
• Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial

  2008cited by this paper
• A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

  2008influential reference
• Medical decision‐making capacity in cognitively impaired Parkinson's disease patients without dementia

  2008cited by this paper
• Practicality of a computerized system for cognitive assessment in the elderly

  2008cited by this paper
• The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease

  2008cited by this paper
• Validity of the Mindstreams™ computerized cognitive battery for mild cognitive impairment

  2007cited by this paper
• The Montreal Cognitive Assessment: Validity and Utility in a Memory Clinic Setting

  2007cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• A Common Cognitive Profile in Elderly Fallers and in Patients with Parkinson's Disease: The Prominence of Impaired Executive Function and Attention

  2006cited by this paper
• Computerized cognitive testing battery identifies mild cognitive impairment and mild dementia even in the presence of depressive symptoms

  2006cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).

  2005cited by this paper
• Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

  2003cited by this paper
• Neuropsychological Profile of Patients with Parkinson’s Disease without Dementia

  2003cited by this paper
• Validity of a novel computerized cognitive battery for mild cognitive impairment

  2003influential reference
• Kappa coefficients in medical research

  2002cited by this paper
• The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.

  1999cited by this paper
• Population-based norms for the Mini-Mental State Examination by age and educational level.

  1993cited by this paper
• The Mini‐Mental State Examination: A Comprehensive Review

  1992cited by this paper
• Alzheimer’s Dementia

  1985cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease

  2025cites this paper
• Current Review: Hyperbaric Oxygen Analysis with Appropriate Cognitive Assessment

  2024cites this paper
• Investigating the relationships between motor skills, cognitive status, and area deprivation index in Arizona: a pilot study

  2024cites this paper
• Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions.

  2024cites this paper
• Online cognitive monitoring technology for people with Parkinson’s disease and REM sleep behavioural disorder

  2024cites this paper
• Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests

  2023cites this paper
• Dementia and the aging population: cognitive screening within correctional health.

  2022cites this paper
• A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease—Identifying Those at the Greatest Risk

  2022cites this paper
• Impairments in gait kinematics and postural control may not correlate with dopamine transporter depletion in individuals with mild to moderate Parkinson's disease

  2019cites this paper
• Initial cognitive changes in Parkinson's disease

  2018cites this paper
• Computerized testing in Parkinson’s disease: Performance deficits in relation to standard clinical measures

  2018influential citation
• Effects of schooling on aspects of attention in rural Burkina Faso, West Africa

  2018cites this paper
• Cognitive Screening Instruments

  2017cites this paper
• Some Clinically Useful Information that Neuropsychology Provides Patients, Carepartners, Neurologists, and Neurosurgeons About Deep Brain Stimulation for Parkinson's Disease

  2017cites this paper
• Alterations in conflict monitoring are related to functional connectivity in Parkinson's disease.

  2016cites this paper
• The use of MMSE and MoCA in patients with acute ischemic stroke in clinical

  2016cites this paper
• Use of the Montreal Cognitive Assessment and Alzheimer's Disease‐8 as cognitive screening measures in Parkinson's disease

  2016cites this paper
• Evaluating a Gaming System for Cognitive Screening and Sleep Duration Assessment of Elderly Players: A Pilot Study

  2016cites this paper
• Association between Community Ambulation Walking Patterns and Cognitive Function in Patients with Parkinson's Disease: Further Insights into Motor-Cognitive Links

  2015cites this paper
• The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease

  2014cites this paper
• Cognitive Screening Instruments

  2013cites this paper
• Montreal Cognitive Assessment (MoCA): Concept and Clinical Review

  2013cites this paper
• Applications of Technology in Neuropsychological Assessment

  2013cites this paper
• Changes on brief cognitive instruments over time in Parkinson's disease

  2012cites this paper
• Lower cognitive performance in healthy G2019S LRRK2 mutation carriers

  2012cites this paper
• Cognitive assessment instruments in Parkinson's disease patients undergoing deep brain stimulation

  2012cites this paper
• Improving precision in the quantification of cognition using the Montreal Cognitive Assessment and the Mini-Mental State Examination

  2011cites this paper
• Neuropsychological assessment: a valuable tool in the diagnosis and management of neurological, neurodevelopmental, medical, and psychiatric disorders.

  2011cites this paper
• Disease‐related and genetic correlates of psychotic symptoms in Parkinson's disease

  2011cites this paper
• Cognitive assessment instruments in individuals with parkinson's disease undergoing deep brain stimulation

  2011cites this paper